Peripheral Mechanisms Mediating the Sustained Antidiabetic Action of FGF1 in the Brain.


Journal

Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763

Informations de publication

Date de publication:
03 2019
Historique:
received: 03 05 2018
accepted: 29 10 2018
pubmed: 14 12 2018
medline: 27 8 2019
entrez: 8 12 2018
Statut: ppublish

Résumé

We recently reported that in rodent models of type 2 diabetes (T2D), a single intracerebroventricular (icv) injection of fibroblast growth factor 1 (FGF1) induces remission of hyperglycemia that is sustained for weeks. To clarify the peripheral mechanisms underlying this effect, we used the Zucker diabetic fatty

Identifiants

pubmed: 30523024
pii: db18-0498
doi: 10.2337/db18-0498
pmc: PMC6385755
doi:

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0
Insulin 0
Fibroblast Growth Factor 1 104781-85-3
Glucokinase EC 2.7.1.2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Pagination

654-664

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007028
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK089056
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK083042
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK101997
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK027619
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK017047
Pays : United States
Organisme : NIDDK NIH HHS
ID : K08 DK114474
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK027619
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2018 by the American Diabetes Association.

Références

J Clin Invest. 2012 Jan;122(1):4-12
pubmed: 22214853
Metabolism. 2000 May;49(5):684-8
pubmed: 10831184
Adv Exp Med Biol. 2010;654:463-77
pubmed: 20217510
Metabolism. 1992 Jan;41(1):22-7
pubmed: 1538640
Cell Metab. 2017 Nov 7;26(5):709-718.e3
pubmed: 28988823
J Clin Invest. 2013 Nov;123(11):4799-808
pubmed: 24084738
J Anat. 2010 Nov;217(5):624-30
pubmed: 20807269
Nat Rev Neurosci. 2013 Jan;14(1):24-37
pubmed: 23232606
FASEB J. 2002 Apr;16(6):509-18
pubmed: 11919153
Nat Commun. 2015 Apr 28;6:6980
pubmed: 25916467
Diabetes. 2013 Feb;62(2):392-400
pubmed: 23028137
J Clin Invest. 1973 Jan;52(1):210-4
pubmed: 4682384
Science. 2011 Mar 25;331(6024):1621-4
pubmed: 21436455
Diabetes. 2017 Apr;66(4):823-834
pubmed: 28115396
Gastroenterology. 1996 Mar;110(3):885-93
pubmed: 8608899
Diabetes Care. 2012 May;35(5):1015-20
pubmed: 22456868
Diabetes Obes Metab. 2014 Sep;16 Suppl 1:33-40
pubmed: 25200294
Diabetes. 2015 Jul;64(7):2376-87
pubmed: 25633417
Diabetologia. 2000 Apr;43(4):393-410
pubmed: 10819232
Sci Rep. 2017 Jul 17;7(1):5578
pubmed: 28717164
Diabetes. 1998 Mar;47(3):358-64
pubmed: 9519740
Nature. 2014 Sep 18;513(7518):436-9
pubmed: 25043058
Mol Metab. 2017 Jul 08;6(9):943-957
pubmed: 28951820
Anat Rec A Discov Mol Cell Evol Biol. 2004 Sep;280(1):808-20
pubmed: 15382020
Mol Metab. 2013 Oct 23;3(1):19-28
pubmed: 24567901
Brain Res. 1984 Jun 11;303(1):147-52
pubmed: 6733521
Diabetes. 2005 May;54(5):1324-30
pubmed: 15855316
Diabetes. 2012 Feb;61(2):321-8
pubmed: 22210318
Methods Mol Biol. 2012;933:103-23
pubmed: 22893404
Physiol Rev. 2011 Apr;91(2):389-411
pubmed: 21527729
Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1105-14
pubmed: 19706786
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1730-5
pubmed: 17895283
Nat Med. 2016 Jul;22(7):800-6
pubmed: 27213816
Endocrinology. 2004 Jun;145(6):2594-603
pubmed: 14976145
Mol Metab. 2015 Jun 04;4(8):561-8
pubmed: 26266088
Diabetes Care. 1996 Sep;19(9):1018-30
pubmed: 8875104
Nature. 2013 Nov 7;503(7474):59-66
pubmed: 24201279
Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E9-E16
pubmed: 16105863
Adv Nutr. 2012 May 01;3(3):286-94
pubmed: 22585902
Endocrinology. 2013 Jan;154(1):9-15
pubmed: 23183168
J Clin Invest. 2005 Jun;115(6):1627-35
pubmed: 15902306
Diabetes. 2010 Jul;59(7):1817-24
pubmed: 20357365
Diabetes. 2009 Jan;58(1):78-86
pubmed: 18952838
Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E414-23
pubmed: 15138155
Diabetes. 2016 Sep;65(9):2711-23
pubmed: 27207534
Endocrinology. 2011 Feb;152(2):394-404
pubmed: 21159853

Auteurs

Jarrad M Scarlett (JM)

University of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.
Gastroenterology and Hepatology, Department of Pediatrics, University of Washington, Seattle, WA.

Kenjiro Muta (K)

University of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.

Jenny M Brown (JM)

University of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.

Jennifer M Rojas (JM)

University of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.
Department of Physiology, Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Miles E Matsen (ME)

University of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.

Nikhil K Acharya (NK)

University of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.

Anna Secher (A)

Novo Nordisk A/S, Måløv, Denmark.

Camilla Ingvorsen (C)

Novo Nordisk A/S, Måløv, Denmark.

Rasmus Jorgensen (R)

Novo Nordisk A/S, Måløv, Denmark.

Thomas Høeg-Jensen (T)

Novo Nordisk A/S, Måløv, Denmark.

Darko Stefanovski (D)

New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA.

Richard N Bergman (RN)

Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

Francesca Piccinini (F)

Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

Karl J Kaiyala (KJ)

Department of Oral Health Sciences, School of Dentistry, University of Washington, Seattle, WA.

Masakazu Shiota (M)

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN.

Gregory J Morton (GJ)

University of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA.

Michael W Schwartz (MW)

University of Washington Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA mschwart@u.washington.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH